Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
Clin Nutr ESPEN. 2021 Feb;41:77-87. doi: 10.1016/j.clnesp.2020.11.006. Epub 2020 Dec 2.
There is a general interest in understanding how the consumption of tea impacts cardiovascular function in individuals at risk of developing cardiovascular disease (CVD). The current review focuses on evidence from randomized controlled trials (RCTs) reporting on associations between tea consumption and endothelial function, in the primary and secondary prevention of coronary artery disease (CAD).
PubMed, EMBASE, and Google Scholar databases/search engines were used to identify eligible studies. Included studies had to report on the impact of tea supplementation of endothelial function or CAD related markers. In addition to flow-mediated dilation (FMD), makers of oxidative stress and inflammation such as oxidized low-density lipoprotein and C-reactive protein were considered as determinants of endothelial function. A total of 34 RCTs met the inclusion criteria, and these reported on the impact of tea consumption on endothelial function in individuals at risk of CVD or patients with CAD.
The current qualitative synthesis of literature demonstrates that beyond enhancing nitric oxide bioavailability and lowering blood pressure, regular consumption of tea and its active ingredients such as epigallocatechin gallate may be beneficial in reducing markers of oxidative stress and inflammation. Moreover, the reduction of oxidized low-density lipoprotein and C-reactive protein levels, could be a sign of improved endothelial function in individuals at increased risk of developing CVD.
The cumulative evidence also suggests that the development of epigallocatechin gallate as a nutraceutical or enriching foods with this bioactive compound could be a feasible strategy to improve endothelial function and lower CVD-risk. However, well-designed RCTs are still necessary to confirm long-term benefits of tea consumption on vascular health.
人们普遍关注饮茶对心血管疾病(CVD)高危人群心血管功能的影响。本综述重点关注了关于饮茶与内皮功能之间关联的随机对照试验(RCT)的证据,这些试验主要集中在冠心病(CAD)的一级和二级预防方面。
使用 PubMed、EMBASE 和 Google Scholar 数据库/搜索引擎来确定符合条件的研究。纳入的研究必须报告茶补充剂对内皮功能或 CAD 相关标志物的影响。除了血流介导的扩张(FMD)外,氧化应激和炎症标志物,如氧化型低密度脂蛋白和 C 反应蛋白,也被认为是内皮功能的决定因素。共有 34 项 RCT 符合纳入标准,这些研究报告了饮茶对 CVD 高危人群或 CAD 患者内皮功能的影响。
目前对文献的定性综合表明,除了增强一氧化氮的生物利用度和降低血压外,经常饮茶及其有效成分,如表没食子儿茶素没食子酸酯,可能有助于降低氧化应激和炎症标志物。此外,降低氧化型低密度脂蛋白和 C 反应蛋白水平可能是 CVD 高危人群内皮功能改善的标志。
累积证据还表明,将表没食子儿茶素没食子酸酯开发为营养保健品或在食物中添加这种生物活性化合物,可能是改善内皮功能和降低 CVD 风险的可行策略。然而,仍需要精心设计的 RCT 来确认长期饮茶对血管健康的益处。